Serum samples from 26 monozygotic twin pairs concordant or discordant with regard to inflammatory bowel disease, and rectal biopsies from 42 twins of the same subject group, were examined for IgG subclasses. They were all compared with normal controls. Almost all affected twins were in clinical remission. Paired immunofluorescence staining of the rectal mucosa showed that those with ulcera-
Abstract
Serum samples from 26 '4 Immunoplates with polyclonal antibodies were purchased from Behringwerke A/S, Germany, and the recommendations by the manufacturer were followed. The determination of IgG subclasses 1, 2, 3, and 4 were made by radial immunodiffusion with the use of monoclonal antibodies purchased from Seward Laboratories, UK. The manufacturer's recommendations were followed. All determinations were done twice with variations between the tests of less than ± 10%.
STATISTICAL ANALYSES
The twins were divided into four test groups: twins with ulcerative colitis, healthy twins from discordant twin pairs of whom the affected ones had ulcerative colitis, twins with Crohn's disease, and healthy twins from discordant twin pairs of whom the affected ones had Crohn's disease.
Differences in median cellular proportions of the four IgG subclasses among these groups and in relation to the controls were determined by Wilcoxon's two tailed test for unpaired samples. (SD) . Differences between means were tested with Student's t test and p<005 was considered statistically significant.
Results

SUBCLASS DISTRIBUTION OF IgG PRODUCING CELLS IN INFLAMMATORY BOWEL DISEASE TWINS AND NORMAL COLONIC MUCOSA
In general, there were large variations in cellular subclass distribution among individuals, in the inflammatory bowel disease twins and normal controls. The results for ulcerative colitis twins are compared with controls in Figure 1 . The median proportion of IgGl immunocytes in twins with ulcerative colitis (78-1 %) was significantly higher (p<001) than in controls (55.9%). Conversely, the proportion of IgG2 cells was lower (p<O0Ol) in twins with ulcerative colitis (15.9%) than in controls (34 6%). In discordant twin pairs of whom the diseased twin had ulcerative colitis, the healthy ones tended to have a raised proportion of IgGi cells (64 6%), and the IgG2 cell fraction was significantly (p=005) reduced (19-1%) compared with controls. In contrast, affected Crohn's disease twins showed a wide scatter of results and did not differ significantly from controls in IgGI and IgG2 proportions (Fig 2) . Healthy twins from pairs with Crohn's disease nevertheless showed a marginally raised IgGI percentage (67.4%; p= 005). A trend towards reduced proportions of IgG3 in affected ulcerative colitis twins, and IgG4 in affected Crohn's disease twins was also noted, but this was not statistically significant.
Median proportions ofIgGi and IgG2 cells did not differ between healthy and diseased twins with either ulcerative colitis or Crohn's disease. The influence of the presence or absence of disease, however, might have been masked by the large individual variations in subclass proportions. The monozygotic twin material consisted of both concordant and discordant twin pairs, and some unpaired healthy twins. Discordant twin pairs with either ulcerative colitis or Crohn's disease, in whom data were available for both twins, were therefore analysed further for both inflammatory bowel disease categories; no significant differences in subclass proportions appeared between healthy and diseased twins (Tables II and III) . Furthermore, the proportions of IgGI cells in healthy and diseased ulcerative colitis twins were well correlated (Fig 3a) . Conversely, no such correlation was found in the discordant Crohn's disease twin pairs (Fig 3b) . The other IgG subclasses were not correlated at the cellular level in either ulcerative colitis or Crohn's disease twins. 16 our study suggests that the cellular IgG subclass distribution in ulcerative colitis does not depend on the magnitude of the local IgG response. The raised IgGI proportion appears to be disease specific instead and not a reflection of unspecific inflammatory changes. The tendency of the healthy ulcerative colitis twins to show a raised IgGI proportion, along with a significantly reduced IgG2 proportion, supports this notion.
The total IgG production in the mucosa was probably not increased in the diseased or healthy ulcerative colitis twins; this could explain the fact that their serum concentrations of IgGl and IgG2 did not differ from controls, which is in contrast with previous observations in active disease.7 There was a tendency towards a lower proportion of IgG3 cells in ulcerative colitis mucosa, along with a significantly decreased serum concentration of IgG3 in ulcerative colitis twins compared with controls. This has not been found in previous studies. Further investigations are needed to determine if also this aberration is specific for ulcerative colitis.
It has been suggested that Crohn's disease gives rise to a relatively enhanced production of IgG2 compared with IgGl,'6' but this did not hold true when we compared immunohistochemical data from our present and previous6 study with controls. On the contrary, there was a tendency towards a reduced proportion of IgG2 in healthy and affected Crohn's disease twins as well as in the previously analysed Crohn's disease colitis patients with moderate or severe mucosal inflammation.6 It rather appeared to be a slight but inconsistent preference for mucosal IgGI production also in Crohn's disease.
There is no doubt that genetic factors are involved in inflammatory bowel disease, although the influence of heredity might be different in the two diseases.817 The genetic impact on the mucosal IgG subclass response could also be different in the two diseases. In ulcerative colitis, we found that the cellular proportions of IgGI and IgG2 in healthy twins were somewhere between controls and affected twins; but when comparing healthy and affected twins, no statistically significant differences appeared. In view of the large individual variations, and also the fact that some twins included were unpaired, the influence of disease might have been more or less masked. We therefore separately analysed six discordant twin pairs, and found no significant differences between healthy and affected twins. Therefore, the factor(s) responsible for the enhanced IgGl response in ulcerative colitis appeared to be present also in healthy twins. This notion was further supported by the strong correlation revealed for cellular IgGl proportions in healthy and affected ulcerative colitis twins.
A possible interpretation of these findings is that genetic mechanisms are involved in the regulation of the IgG subclass response. The switch region associated with the CHyl gene may be more efficient in the ulcerative colitis population. Certain IgG heavy chain markers are associated with the serum concentrations of IgG subclasses. For example, individuals without the G2 marker n have lower serum concentration of IgG2 than carriers of the G2m(n).'8 Another mechanism may be that certain VH genes, directed against antigens which are important to the IgG response in ulcerative colitis, preferentially associate with particular CH genes in the ulcerative colitis population. Several studies have disclosed relations between IgG markers and IgG subclass serum concentrations against particular antigens.'920 Interestingly, a recent German study showed an association between ulcerative colitis and Gm 1,-2,10.2' Similar genetic mechanisms may be involved in autoimmune diseases in general. Several studies have disclosed increased serum levels of IgGI in a number of autoimmune diseases.7 [22] [23] [24] The similarity in IgG subclass proportions between healthy and affected ulcerative colitis twins might also reflect stimulation by a particular antigen(s Conversely, our data strongly suggested a substantial genetic impact on the preferential local IgGI response in ulcerative colitis.
